{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:28:07Z","timestamp":1787761687383,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Epilepsy is one of the major neuron-damaging neurological disorders. Generalized tonic-clonic seizure (GTCS) is the commonest one. Refractory patterns cannot be controlled by simple monotherapy with antiepileptic drugs (AEDs). Valproic acid (VPA) is one of the widely prescribed AEDs but it may not control many cases up to its maximum tolerable doses. In this study, we have seen the safety and efficacy of clobazam to control seizure in the adult population as an add-on drug over valproate, in cases of valproate uncontrolled seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Patients on VPA monotherapy but not responding to it were recruited after applying inclusion and exclusion criteria and clobazam was added. There were two follow-ups at the interval of 6 months each. Seizure frequency and quality of life inventory in epilepsy-31 items (QOLIE-31) score were recorded to denote efficacy, and the occurrence of any adverse effect was also noted to elicit safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Out of 101 patients, 78 were male and 23 were female. The most common age group was 18\u201330 y. Seizure frequency from 2.99 \u00b1 0.95 decreased significantly on the third visit to 0.25 \u00b1 0.43. QOLIE-31 scores of seizure worry, overall quality, emotional well-being, and cognition improved in the second follow-up. Fatigue, somnolence, and weight gain were the major side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Clobazam could be a good choice as an add-on in GTCS not controlled with VPA monotherapy. Clobazam definitely reduces seizure frequency and seizure worry and improves cognitive function and overall quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_1347_22","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:17:05Z","timestamp":1682659025000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of efficacy and safety of clobazam as an add-on drug in the treatment of generalized tonic-clonic seizure not controlled with valproic acid monotherapy"],"prefix":"10.4103","volume":"12","author":[{"given":"Somenath","family":"Das","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Deben Mahata Government Medical College and Hospital, Purulia, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonai","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Bankura Sammilani Medical College and Hospital, Bankura, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamoghna","family":"Maiti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Bankura Sammilani Medical College and Hospital, Bankura, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Bankura Sammilani Medical College and Hospital, Bankura, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0972-2327.160093","article-title":"Epilepsy in India I: Epidemiology and public health","volume":"18","author":"Amudhan","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1528-1157.1988.tb04405.x","article-title":"Prevalence of epilepsy in the Parsi community of Bombay","volume":"29","author":"Bharucha","year":"1988","journal-title":"Epilepsia"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1528-1157.2001.32800.x","article-title":"The treatment gap in epilepsy: The current situation and ways forward","volume":"42","author":"Meinardi","year":"2001","journal-title":"Epilepsia"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S0317167100030651","article-title":"Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood","volume":"17","author":"Keene","year":"1990","journal-title":"Can J Neurol Sci"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2016.09.032","article-title":"Quality of life in epilepsy-31 inventory (QOLIE-31) scores: A global comparison","volume":"65","author":"Saadi","year":"2016","journal-title":"Epilepsy Behav"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S0004-282X2010000200024","article-title":"Modification in body weight associated with antiepileptic drugs","volume":"68","author":"Gaspari","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"key":"R9-20240829","first-page":"209","article-title":"Effect of clobazam as add-on antiepileptic drug in patients with epilepsy","volume":"140","author":"Joshi","year":"2014","journal-title":"Indian J Med Res"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1752-1947-6-239","article-title":"Anemia secondary to valproic acid therapy in a 13-year-old boy: A case report","volume":"6","author":"Kaczorowska-Hac","year":"2012","journal-title":"J Med Case Rep"},{"key":"R11-20240829","first-page":"296","article-title":"A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety","volume":"44","author":"Jacobson","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.28.9.961","article-title":"Effect of valproic acid on hepatic function","volume":"28","author":"Wilmore","year":"1978","journal-title":"Neurology"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/appi.ajp.160.1.174","article-title":"The safety of valproic acid use for patients with hepatitis C infection","volume":"160","author":"Felker","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1528-1157.2001.31600.x","article-title":"Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy","volume":"42","author":"Montenegro","year":"2001","journal-title":"Epilepsia"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1590\/S0004-282X2006000500001","article-title":"Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy","volume":"64","author":"da Silveira","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S0317167100004996","article-title":"Clobazam as add-on therapy in children with epileptic encephalopathy","volume":"33","author":"Silva","year":"2006","journal-title":"Can J Neurol Sci"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1528-1157.1998.tb05116.x","article-title":"Aggravation of focal epileptic seizures by antiepileptic drugs","volume":"39","author":"Elger","year":"1998","journal-title":"Epilepsia"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5958\/2395-1184.2018.00003.7","article-title":"Effect of Clobazam as add-on antiepileptic drug in patients with epilepsy","volume":"4","author":"Kumar","year":"2018","journal-title":"Int J Contemp Pathol"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/0883073819836534","article-title":"Evaluation of the effects of clobazam on seizure control and quality of life in children with Lennox-Gastaut syndrome: A pilot study","volume":"34","author":"Weinstock","year":"2019","journal-title":"J Child Neurol"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nurt.2006.11.002","article-title":"Clobazam","volume":"4","author":"Ng","year":"2007","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1347_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:04:09Z","timestamp":1787760249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1347_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_1347_22","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}